How Data And Trust Are Reshaping ADHD Treatment with Danielle Vaeth, Head of Strategic Development and Enterprise Sales at Qbtech

Objective data is becoming essential to building trust, reducing bias, and personalizing ADHD care at scale. In this episode, Danielle Vaeth, Head of Strategic Development and Enterprise Sales at Qbtech, discusses how technology is reshaping the assessment and management of ADHD through objective measurement and data-driven insights. She explains why rating scales remain important but incomplete due to bias, stigma, and variability, and how adding objective measures can strengthen clinical confidence, patient trust, and treatment optimization. Danielle examines the gradual yet significant development of behavioral health technology, the impact of access and equity, and the increasing importance of software-driven tools in both urban and rural care settings. She also shares how machine learning and personalized data are shaping the future of ADHD treatment, why measuring outcomes is critical for value-based care, and how aligning incentives across clinicians, patients, and payers can drive better results. Tune in and learn how objective data, technology, and incentives can transform ADHD care over the next five years! Resources: Connect with and follow Danielle Vaeth on LinkedIn. Follow Qbtech on LinkedIn and explore their website.